-+ 0.00%
-+ 0.00%
-+ 0.00%

PERSPECTIVE THERAPEUTICS, - CO SPONSORS STUDY; MERCK PROVIDES PEMBROLIZUMAB AT NO COST

路透·09/14/2026 10:16:00

登录查看新闻详情